Standard Chemical & Pharmaceutical Co (TPE:1720) Ending Cash Position : NT$1,891 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co Ending Cash Position?

Standard Chemical & Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was NT$1,891 Mil.

Standard Chemical & Pharmaceutical Co's quarterly Ending Cash Position declined from Jun. 2023 (NT$2,294 Mil) to Sep. 2023 (NT$1,956 Mil) and declined from Sep. 2023 (NT$1,956 Mil) to Mar. 2024 (NT$1,891 Mil).

Standard Chemical & Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2020 (NT$1,036 Mil) to Dec. 2021 (NT$2,564 Mil) but then declined from Dec. 2021 (NT$2,564 Mil) to Dec. 2022 (NT$2,259 Mil).

Standard Chemical & Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Standard Chemical & Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard Chemical & Pharmaceutical Co Ending Cash Position Chart

Standard Chemical & Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

1,254.06

1,471.90

1,036.18

2,564.40

2,259.38

Standard Chemical & Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															2,259.38	2,295.51	2,293.96	1,956.26	1,890.59

Standard Chemical & Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Standard Chemical & Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2564.395	+	-305.014
	=	2,259

Standard Chemical & Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2036.743	+	-146.156
	=	1,891

Standard Chemical & Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055

Website

https://www.standard.com.tw

Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines